BioHealth News Archive
Paula Sorrell leads George Mason University entrepreneurship – Washington Business Journal
She aims to have a big presence in the local business community. Image: Paula Sorrell is the new associate vice president of innovation and…
Read MoreAdaptive Phage Therapeutics gets FDA green light to advance superbug therapy, as COVID-19 ‘underscores the critical need’ – Washington Business Journal
Adaptive Phage Therapeutics can take its therapy for superbugs to human trials. Image: Dr. Carl Merril, third from right, with his son Greg, CEO…
Read MoreQuickFire Challenge Awardees Recognized at HLTH VRTL 2020 – News | JLABS
October 14, 2020 – Johnson & Johnson Innovation announced today at the virtual 2020 HLTH conference the awardees for the JLABS @ Washington, DC…
Read MoreEight Innovative, Virginia Life Science Startups to Know · BioBuzz
At BioBuzz, we’re dedicated to bringing you interesting and important stories that emerge from the thriving life sciences ecosystem that is the BioHealth Capital…
Read MoreThe Washington Post Announces Top Workplace Rankings | Emmes
Emmes today announced that it was selected as one of the best places to work in the greater Washington area. The Washington Post’s 2020…
Read Morecitybizlist : Washington DC : Need Startup Funding? Here Are 65 Venture Capital Firms in the Baltimore-DC Region
If you’re located in New York City or the Silicon Valley, venture capital firms are abundant and well covered by the media — you…
Read MoreFDA Veteran Outlines Plans to Increase Diversity in Medtech Industry
What is MedTech Color? MedTech Color is a non-profit organization focused on ensuring people of color enter, remain, and flourish in the medtech industry.…
Read MoreFDA Commissioner Says Panel Must Review COVID Vaccine
JOHN WHYTE: You're watching "Coronavirus in Context." I'm Dr. John Whyte, chief medical officer at WebMD. Today I'm joined by Dr. Stephen Hahn. He's…
Read MoreTrump Administration Expands Collaboration With AstraZeneca to Develop and Manufacture an Investigational Monoclonal Antibody to Prevent COVID-19 > U.S. DEPARTMENT OF DEFENSE > Release
To meet the Trump Administration’s Operation Warp Speed goals, the U.S. Department of Health and Human Services (HHS) and Department of Defense (DOD) today…
Read MoreCan culture and community drive success? – Research & Development World
Not every research project succeeds. And not every company survives. However, the ones that align with the culture of winning and sign up and…
Read MoreMontgomery County Executive Marc Elrich joins Rich Bendis on BioTalk
Montgomery County Executive Marc Elrich joins BioTalk to discuss his Career Path, the BioHealth Industry and plans to support the Industry in MoCo. Listen…
Read MoreJustin Yang, Biomedical Advanced Research and Development Authority (BARDA) Director of the DRIVe Catalyst Office, Joins Rich Bendis on BioTalk
BARDA Director of the DRIVe Catalyst Office, Justin Yang, Joins BioTalk to share how BARDA collaborates with the BioHealth Industry, partners with Incubators, and…
Read MoreHow This Med Tech Startup Pivoted to Fight the Pandemic
Across the world in 2019, UNICEF reports that over 2.4 million infants died in their first month of life, the vast majority in the…
Read MoreChildren’s National Hospital earns 2020 CHIME Digital Health Most Wired recognition | Children’s National Hospital
Children’s National Hospital has received 2020 Digital Health Most Wired recognition by The College of Healthcare Information Management Executives (CHIME) as a certified level…
Read MoreFDA Grants GlycoMimetics Rare Pediatric Disease Designation for Rivipansel for Treatment of Sickle Cell Disease – BioHealth Capital Region
ROCKVILLE, Md.–(BUSINESS WIRE)–Oct. 5, 2020– GlycoMimetics, Inc. (Nasdaq: GLYC) today announced that the U.S. Food and Drug Administration (FDA) has granted the Company a Rare Pediatric Disease designation…
Read More